GSK3B and schizophrenia: a case not closed

Psychopharmacology (Berl). 2010 Feb;208(2):333-4; author reply 335-6. doi: 10.1007/s00213-009-1728-8. Epub 2009 Nov 24.

Authors

Philipp G Sand, Martina Domani, Stefan Smesny

PMID: 19936977
DOI: 10.1007/s00213-009-1728-8

No abstract available

Publication types

Letter
Comment

MeSH terms

Antipsychotic Agents / therapeutic use
Clozapine / therapeutic use
Evidence-Based Medicine
Gene Frequency
Genetic Predisposition to Disease
Glycogen Synthase Kinase 3 / genetics*
Glycogen Synthase Kinase 3 / metabolism
Glycogen Synthase Kinase 3 beta
Humans
Phenotype
Polymorphism, Genetic*
Risk Assessment
Risk Factors
Schizophrenia / drug therapy
Schizophrenia / enzymology
Schizophrenia / genetics*
Treatment Outcome

Substances

Antipsychotic Agents
GSK3B protein, human
Glycogen Synthase Kinase 3 beta
Glycogen Synthase Kinase 3
Clozapine